Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis

• Main Authors: Jianhua Wu (Author), Liu Zhang (Author), Xi Zhou (Author), Jiajun Wang (Author), Xiangyi Zheng (Author), Hankun Hu (Author), Dongfang Wu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose: Recently, the U.S. Food and Drug Administration (FDA) approved stiripentol, cannabidiol, and fenfluramine to treat patients with Dravet syndrome (DS). Moreover, soticlestat was determined as a promising new drug for the treatment of DS as it has good efficacy and safety. However, the effica...